Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference48 articles.
1. Novel hypothesis to explain why SGLT2 inhibitors inhibit only 30-50% of filtered glucose load in humans;Abdul-Ghani;Diabetes,2013
2. On the action of phlorizin;Stiles;Am J Phys,1903
3. Biology of human sodium glucose transporters;Wright;Physiol Rev,2011
4. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats;Rossetti;J Clin Invest,1987
5. Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study;Leiter;Diabetes Care,2015
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease;Frontiers in Endocrinology;2023-12-20
2. Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease;Physiological Reports;2023-11
3. Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart;Hypertension;2023-09
4. Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis;Endocrinology and Metabolism;2023-08-31
5. The Interplay between Immune and Metabolic Pathways in Kidney Disease;Cells;2023-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3